Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June-2023 Volume 25 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures

  • Authors:
    • Takuya Usami
    • Naoya Takada
    • Hidetoshi Iwata
    • Hiroaki Sakai
    • Yusuke Hattori
    • Isato Sekiya
    • Yoshino Ueki
    • Yuko Nagaya
    • Hideki Murakami
    • Gen Kuroyanagi
  • View Affiliations / Copyright

    Affiliations: Department of Orthopedic Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Aichi 467‑8601, Japan, Department of Orthopedic Surgery, Kainan Hospital, Yatomi, Aichi 498‑8502, Japan, Department of Orthopedic Surgery, Nagoya City University East Medical Center, Nagoya, Aichi 464‑8547, Japan
  • Article Number: 256
    |
    Published online on: April 18, 2023
       https://doi.org/10.3892/etm.2023.11955
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Hydroxyapatite (HA) augments are used to treat trochanteric femoral fractures. However, the efficacy of HA augmentation has not been fully described in trochanteric femoral fracture surgery. In total, 85 patients were enrolled in the present study; all had trochanteric femoral fractures between January 2016 and October 2020, 45 with HA (HA group) and 40 without HA (N group). The intraoperative lag screw insertion torque was directly measured and the amount of lag screw telescoping with and without HA augmentation after surgery was analyzed. Maximum lag screw insertion torque (max‑torque), bone mineral density in the opposite femoral neck (n‑BMD), tip apex distance (TAD) of the lag screw, radiographic findings including fracture union, the amounts of lag screw telescoping and occurrence of complications were evaluated. A total of 12 patients were excluded if they were aged under 60 years old, had ipsilateral surgery and disorders in the hip joint, TAD of the lag screw ≥26 mm on postoperative radiographs and had measurement errors. A total of 73 fractures could be analyzed: HA group (n=36) and N group (n=37). Max‑torque/n‑BMD ratios were higher in the HA group compared with in the N group (7.23±2.71 vs. 5.93±1.91 g/cm2·N·m; P=0.04). The amounts of lag screw telescoping in the HA group were smaller compared with the N group (1.41±2.00 vs. 2.58±2.34; P=0.05). Evaluation of screw insertion torque showed maximum screw insertion torque correlated well with n‑BMD in both groups, HA (R=0.57; P<0.01) and N group (R=0.64; P<0.01). No correlation was found between maximum screw insertion torque and TAD in both groups, HA (R=‑0.10; P=0.62) and N group (R=0.02; P=0.93). All fractures were radiographically united without any complications. These results support the effectiveness of HA augmentation, indicating higher resistance against rotational instability and reduced lag screw telescoping in trochanteric femoral fracture treatment.

Introduction

The incidence of trochanteric femoral fractures has increased owing to an aging society (1). Falling is one of the main causes of fracture Hydroxyapatite (HA) augments are used to treat trochanteric femoral fractures. However, the efficacy of HA augmentation has not been fully described in trochanteric femoral fracture surgery. In total, 85 patients were enrolled in the present study; all had trochanteric femoral fractures between January 2016 and October 2020, 45 with HA (HA group) and 40 without HA (N group). The intraoperative lag screw insertion torque was directly measured and the amount of lag screw telescoping with and without HA augmentation after surgery was analyzed. Maximum lag screw insertion torque (max-torque), bone mineral density in the opposite femoral neck (n-BMD), tip apex distance (TAD) of the lag screw, radiographic findings including fracture union, the amounts of lag screw telescoping and occurrence of complications were evaluated. A total of 12 patients were excluded if they were aged under 60 years old, had ipsilateral surgery and disorders in the hip joint, TAD of the lag screw ≥26 mm on postoperative radiographs and had measurement errors. A total of 73 fractures could be analyzed: HA group (n=36) and N group (n=37). Max-torque/n-BMD ratios were higher in the HA group compared with in the N group (7.23±2.71 vs. 5.93±1.91 g/cm2·N·m; P=0.04). The amounts of lag screw telescoping in the HA group were smaller compared with the N group (1.41±2.00 vs. 2.58±2.34; P=0.05). Evaluation of screw insertion torque showed maximum screw insertion torque correlated well with n-BMD in both groups, HA (R=0.57; P<0.01) and N group (R=0.64; P<0.01). No correlation was found between maximum screw insertion torque and TAD in both groups, HA (R=-0.10; P=0.62) and N group (R=0.02; P=0.93). All fractures were radiographically united without any complications. These results support the effectiveness of HA augmentation, indicating higher resistance against rotational instability and reduced lag screw telescoping in trochanteric femoral fracture treatment.

and is related to high mortality rates (2,3). Open reduction and internal fixation using an intramedullary nail is the most commonly used operative method for fractures (4). Many implant designs and augmentation methods have been reported to increase the initial fixation strength (5,6). However, complications such as necrosis of the femoral head and cut-out of the lag screw are problematic due to lower bone mineral density (BMD) (7,8). The uses of cement augmentation involve fixation of the femoral head screw (9,10). While cement augmentation reportedly increases the lag screw fixation force (11,12), cement usage is a risk factor for femoral head necrosis due to the chemical and heat reactions (9,13-16). Hydroxyapatite (HA) augmentation has the advantage of high biomechanical and biochemical stability after implantation. HA augmentation is widely used in the treatment of trochanteric femoral fracture, distal radial fracture, proximal tibial fracture, and spinal surgery (17,18). HA augmentation reportedly increases peri-implant bone formation after surgery and demonstrates increased cut-out resistance (17,19,20). In this study, Neobrace® (Neobrace®, Aimedic MMT Co., Ltd., Japan) was used for HA augmentation. This is a cylinder-shaped implant with a length of 25 mm, inner diameter of 3.5 mm, and outer diameter of 7 mm (Fig. 1A). Neobrace® is composed of pure HA particles with a porosity of 72-78% and a diameter of 150-200 µm. Neobrace® was easily collapsed by lag screw insertion into comminuted granules and was scattered around the screws (Fig. 1B). The granule size was 40-70 µm, which was sufficiently strong (12-18 MPa). HA granules have advantages such as high biocompatibility, as HA is the main composite of bone.

Figure 1

(A) HA tube. (B) HA tube was crushed and scattered around the lag screw in a model bone. HA, hydroxyapatite.

Evaluation of the postoperative risk of lag screw cut-out during surgery is difficult. It has been reported that the insertion torque of the screw is a key predictor for evaluating the cut-out resistance force (21-23). Local BMD [e.g. BMD around femoral neck (n-BMD)] and force at cut-out are highly correlated with maximum screw insertion torque (21-23). Thus, we calculated max-torque/n-BMD ratio because this would be a good surrogate parameter to indicate bone strength. Moreover, it indicates that max-torque/n-BMD ratio should be statistically similar to each other compared to each specimen. Our previous study showed that the mean lag screw insertion torque (mean torque)/screw insertion and n-BMD increased with the use of a HA tube in the treatment of trochanteric femoral fractures (24). However, the maximum lag screw insertion torque (max-torque)/n-BMD did not reach significance as noise in the raw data made statistical analysis difficult. The purpose of this study was to investigate the effectiveness of HA augmentation in the treatment of trochanteric femoral fractures using novel data-smoothing techniques. We measured the lag screw insertion torque and n-BMD with and without HA augmentation during the surgery and subsequently evaluated the effects of HA augmentation on max-torque/n-BMD. Moreover, the amount of lag screw telescoping with and without postoperative HA augmentation was evaluated.

Materials and methods

Patients' selection and exclusion

This study was approved by the Research Ethics Committee of Kainan Hospital. Written informed consent was obtained from all participants before surgery. Between January 2016 and October 2020, 85 patients with closed trochanteric femoral fractures treated using Gamma3® (Stryker, MI, USA) were enrolled in the study. The mean age of all patients was 83.8±8.4 years (median, 84; range, 54-102). A tip apex distance (TAD)-the distance from the apex of the femoral head to the tip of the lag screw on anteroposterior and lateral radiographs-greater than 25 mm identified the risk for cut-out (25,26). Therefore, patients were excluded if they were aged less than 60 years, had ipsilateral surgery and disorders in the hip joint, and TAD of the lag screw ≥26 mm on postoperative radiographs (Fig. 2).

Figure 2

Overview of the selection of patients. HA, hydroxyapatite; N, without HA; TAD, tip apex distance of the lag screw.

Measurement method and data analysis

Surgery was conducted under lumbar or general anesthesia. In the HA group, we used 2 Neobrace® before lag screw insertion via the lag screw hole (Fig. 1). The lag screw insertion torque was obtained continuously using a digital torque measurement device (HTGS-5N, 10N, Imada Co., Ltd., Tokyo, Japan), and the data were recorded using the software (Force Recorder, Imada Co., Ltd., Japan) (Fig. 3). The sampling rate was 2,000 Hz. The lag screw was manually inserted using a digital torque measurement device connected to a screwdriver. Data were excluded if the measurements exceeded the upper limit and had measurement error (Fig. 2). The data were described as time-series scatterplots with noise, and the locally weighted scatterplot smoothing (LOWESS) technique was adopted to smooth the data series in this study (27). The library and application programming interface, including NumPy, SciPy, and statsmodels.api, were imported into Python (Python Software Foundation, Wilmington, USA). The function statsmodels.nonparametric.smoothers_lowess.lowess was used to smoothen the data series (parameter: frac=0.01). This method enabled the visualization of numerous data series of torque. As previously described, a normal graph of the screw insertion torque exhibits a plateau torque pattern followed by a clear peak (27). Thus, we excluded data that had no exact plateau and/or peak and exceeded the upper limit of the torque gauge in this study. The function scipy.signal.find_peaks was used to obtain the peak of the smoothed data (parameters: height=0.3, distance=500). The highest peak of lag screw insertion torque was defined as the max-torque.

Figure 3

(A) The examination system connected to the lag screw handle and a laptop computer. (B) Intraoperative examination picture showing the lag screw inserted through the torque-measuring device.

The n-BMD was calculated using a dual-energy X-ray absorptiometry (DEXA) machine (DCS-900EX, Hitachi, Ltd., Tokyo, Japan). TAD of the lag screw was measured on postoperative radiographs at the final follow-up. Radiographical evidence of fracture union and postoperative complications was also assessed at the final follow-up. The amount of lag screw telescoping and radiographic evidence of fracture union at the final follow-up were evaluated by a single surgeon.

Statistical analysis

Both categorical and continuous variables including patients' age, sex, operative side, follow-up duration, n-BMD, max-torque/n-BMD, TAD of the lag screw, amount of lag screw telescoping, radiographical evidence of fracture union, and complications were evaluated using Fisher's exact test and Welch's t-test. Pearson's correlation and overall agreement were calculated to assess the reliability of each parameter, including max-torque, n-BMD, and TAD, in the two groups. Statistical analysis was conducted using the R statistical package, version 4.0.4 (R Core Team, Foundation for Statistical Computing, Austria). All reported two-sided P-values were evaluated, and P-values <0.05 were considered statistically significant.

Results

Among the 85 patients enrolled, 12 patients were excluded (Fig. 2). Thus, a total of 73 patients (patients with the use of HA augments: HA group, n=36; patients without the use of augments: N group, n=37) were analyzed in the study. The mean age of participants was 83.4±7.9 years (range, 63-95) in the HA group and 85.7±7.7 years (range, 67-107) in the N group (P=0.22). There were 10 males and 26 females in the HA group and 8 males and 29 females in the N group (P=0.60). Operative sides of the HA and N groups were 18 right and 18 left sides and 20 right and 17 left sides, respectively (P=0.82). The follow-up durations were 11.88±14.56 months (range, 0.23-62.00) in the HA group and 9.87±13.14 months (range, 0.20-12.00) in the N group (P=0.54). n-BMD was 0.45±0.11 g/cm2 (range, 0.25-0.64) in the HA group and 0.48±0.13 g/cm2 (range, 0.25-0.86) in the N group (P=0.26).

Max-torque was 3.26±1.49 N·m (range, 1.08-8.50) in the HA group and 2.76±1.16 N·m (range, 0.92-6.03) in the N group (P=0.11). Max-torque/n-BMD was 7.23±2.71 g/cm2·N·m (range, 2.51-13.26) in the HA group and 5.93±1.91 g/cm2·N·m (range, 3.29-12.25) in the N group (P=0.04). TAD was 18.89±4.38 mm (range, 9.11-25.82) in the HA group and 18.32±3.72 mm (range, 10.70-25.16) in the N group (P=0.60). The amounts of lag screw telescoping was 1.41±2.00 mm (range, 0-8.81) in the HA group and 2.58±2.34 mm (range, 0-7.47) in the N group (P=0.05) (Table I).

Table I

Overview of preoperative variables in the HA and N groups.

Table I

Overview of preoperative variables in the HA and N groups.

Preoperative variablesHA group (n=36)N group (n=37)P-value
Age, years (range)83.4±7.93 (63-95)85.7±7.70 (67-107)0.22
Sex  0.60
     Male108 
     Female2629 
Side  0.82
     Right1820 
     Left1817 
Follow-up duration, months (range)11.88±14.56 (0.23-62.00)9.87±13.14 (0.20-12.00)0.54
n-BMD, g/cm2 (range)0.45±0.11 (0.25-0.64)0.48±0.13 (0.25-0.86)0.26
Max-torque, N·m (range)3.26±1.49 (1.08-8.50)2.76±1.16 (0.92-6.03)0.11
Max toqrue/n-BMD, g/cm2·N·m (range)7.23±2.71 (2.51-13.26)5.93±1.91 (3.29-12.25)0.04a
TAD, mm (range)18.89±4.38 (9.11-25.82)18.32±3.72 (10.70-25.16)0.60
Telescoping, mm (range)1.41±2.00 (0-8.81)2.58±2.34 (0-7.47)0.05
ComplicationsN/AN/A 

[i] aP<0.05. HA, hydroxyapatite; N, without HA; n-BMD, bone mineral density of the uninjured opposite side of femoral neck; Max-torque, maximum screw insertion torque; TAD, tip apex distance of the lag screw; N/A, not applicable.

Regarding the relationships between the max-torque and n-BMD, the values of correlation coefficients were 0.57 in the HA group (P<0.01) and 0.64 in the N group (P<0.01). In the relationship between the max-torque and TAD, the values of the correlation coefficients were -0.10 in the HA group (P=0.62) and 0.02 in the N group (P=0.93) (Table II). All fractures were radiographically united without any complications.

Table II

Pearson's correlation and overall agreement between max-torque and n-BMD and TAD.

Table II

Pearson's correlation and overall agreement between max-torque and n-BMD and TAD.

VariablesCorrelationLower limitUpper limitP-value
n-BMD    
     HA group0.570.260.77 <0.01a
     N group0.640.370.81 <0.01a
TAD    
     HA group-0.10-0.450.280.62
     N group0.02-0.350.380.93

[i] aP<0.05. HA, hydroxyapatite; N, without HA; n-BMD, bone mineral density of the uninjured opposite side of femoral neck; Max-torque, maximum screw insertion torque; TAD, tip apex distance of the lag screw.

Discussion

In this study, we examined the mechanical effects of HA augmentation in the treatment of trochanteric femoral fractures. Our analyses identified a significantly positive relationship between max-torque and BMD with and without HA augmentation. Our previous study demonstrated that lag screw insertion torque was related to screw cut-out resistance by analyzing the mean torque/n-BMD (24). However, the study did not show statistical significance in max-torque/n-BMD between the groups with and without HA augmentation. We concluded in this study that the measurement noise may cause statistical dispersion (22). However, this current study shows that max-torque/n-BMD was significantly higher in the presence of HA tubes. This is the first study to use Python, LOWESS, and the scipy.signal.find_peaks function. The sampling rate obtained from the torque gauge was 2,000 Hz, therefore, the total number of data series ranged from 50,000 to 100,000 plots with noise for each trial. The methods of data smoothing and peak extraction were effectively used to grasp the trends of the data series. LOWESS is a locally weighted nonparametric regression analysis method. Thus, the data curves calculated by LOWESS can be accurately fitted to the data, such as the manually measured torque. This is the first biomechanical study to show the effectiveness of LOWESS for analyzing nonparametric data.

Regarding radiologic parameters, we used intramedullary nails with neck-shaft angle of 125˚ for all cases. We tried to calculate the neck shaft angle of the proximal femur. However, the differences in the external rotation on radiographs made the calculation difficult. Further examination should be performed by using CT scans to clarify the details of radiologic parameters. Instead of angle parameters, we measured the telescoping amount of lag screws and found that the amounts of lag screw telescoping were lower in the HA group than that in the N group. Thus, it seems likely that the HA augments may increase the fixation of lag screws in the treatment of trochanteric femoral fractures. As for TAD, the distribution of BMD is reportedly higher on the outer side of the femoral head than on the inner side (28). Another study showed a TAD >25 mm is a predictor of postoperative cut-out (26). In this study, there was no observed association between TAD and max-torque in cases with TAD ≤25 mm. This suggests that when the lag screw is inserted deeper than 25 mm, the lag screw insertion torque is sufficiently high enough to prevent postoperative cut-out. Based on these results, it is likely that HA augmentation would be the optimal approach to improve screw pull-out strength and to reduce the risk of screw cut-out in the treatment of trochanteric femoral fracture (22,23,29).

In this study, no complications were reported during the follow-up period. By contrast, cement augmentation is reportedly related to thermal osteonecrosis and bone cement syndrome, resulting in postoperative lag screw cut-out (9,13-16). Therefore, we believe that HA augmentation may be safer than cement augmentation in the treatment of trochanteric femoral fractures. Yamada et al (30) reported that HA-coated titanium implants would induce bone regeneration around the implant after the surgery. There may be an additional benefit of this surgical treatment that new bone formation would be induced. In this study, we could not find new bone formation in the analysis of postoperative radiographs. Quantitative analysis such as Quantitative Computed Tomography and DEXA around the screw would be needed to evaluate this effect.

Several limitations should be considered when interpreting the results of this study. Namely, the lack of postoperative clinical evaluations and the small sample size, made statistical evaluation difficult. Further studies are needed to evaluate the exact effects of HA augmentation in the treatment of trochanteric femoral fractures.

In conclusion, the max-torque/n-BMD ratio is improved by HA augmentation in the treatment of trochanteric femoral fracture surgery. Moreover, HA augmentation could increase the bone-implant interface and decrease the risk of cut-out after surgery.

Acknowledgements

Not applicable.

Funding

Funding: The present study was partly supported by a Grant-in-Aid for Scientific Research (grant no. 19K18471) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and a Grant-in-Aid for Research (grant no. 2213035) from Nagoya City University.

Availability of data and materials

The datasets generated and/or analyzed during the current study are available on the figshare repository (URL: https://doi.org/10.6084/m9.figshare.21308985).

Authors' contributions

TU wrote the original draft, acquired, analyzed, and interpreted the data and acquired the funding. NT conceived and designed this study, and wrote the original draft. HI acquired, analyzed and interpreted the data. GK wrote the original draft, analyzed and interpreted the data, and acquired the funding. HS, YH and IS analyzed and interpreted the data. YU, YN and HM reviewed the original draft, analyzed and interpreted the data, and administrated the project and resources. TU and NT confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

This study was approved by the Research Ethics Committee of Kainan Hospital (approval no. 20230413-01). Written informed consent was obtained from all participants before surgery.

Patient consent for publication

Written informed consent for the publication of any data and/or accompanying images was obtained from all patients preoperatively.

Competing interests

The authors declare that they have no competing interests.

References

1 

Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I and Järvinen M: Epidemiology of hip fractures. Bone. 18 (1 Suppl):S57–S63. 1996.PubMed/NCBI View Article : Google Scholar

2 

Hayes WC, Myers ER, Robinovitch SN, Van Den Kroonenberg A, Courtney AC and McMahon TA: Etiology and prevention of age-related hip fractures. Bone. 18 (1 Suppl):77S–86S. 1996.PubMed/NCBI View Article : Google Scholar

3 

Holt G, Smith R, Duncan K, Finlayson DF and Gregori A: Early mortality after surgical fixation of hip fractures in the elderly: An analysis of data from the scottish hip fracture audit. J Bone Joint Surg Br. 90:1357–1363. 2008.PubMed/NCBI View Article : Google Scholar

4 

Bartoníček J and Rammelt S: The history of internal fixation of proximal femur fractures Ernst Pohl-the genius behind. Int Orthop. 38:2421–2426. 2014.PubMed/NCBI View Article : Google Scholar

5 

Usami T, Takada N, Nishida K, Sakai H, Iwata H, Sekiya I, Ueki Y, Murakami H and Kuroyanagi G: Banding with lesser trochanter fragment using nonabsorbable tape in trochanteric femoral fractures. SICOT J. 7(33)2021.PubMed/NCBI View Article : Google Scholar

6 

Socci AR, Casemyr NE, Leslie MP and Baumgaertner MR: Implant options for the treatment of intertrochanteric fractures of the hip: Rationale, evidence, and recommendations. Bone Joint J. 99-B:128–133. 2017.PubMed/NCBI View Article : Google Scholar

7 

Yu X, Wang H, Duan X, Liu M and Xiang Z: Intramedullary versus extramedullary internal fixation for unstable intertrochanteric fracture, a meta-analysis. Acta Orthop Traumatol Turc. 52:299–307. 2018.PubMed/NCBI View Article : Google Scholar

8 

Barrios C, Broström LA, Stark A and Walheim G: Healing complications after internal fixation of trochanteric hip fractures: The prognostic value of osteoporosis. J Orthop Trauma. 7:438–442. 1993.PubMed/NCBI View Article : Google Scholar

9 

Cheng CL, Chow SP, Pun WK and Leong JC: Long-term results and complications of cement augmentation in the treatment of unstable trochanteric fractures. Injury. 20:134–138. 1989.PubMed/NCBI View Article : Google Scholar

10 

Kammerlander C, Gebhard F, Meier C, Lenich A, Linhart W, Clasbrummel B, Neubauer-Gartzke T, Garcia-Alonso M, Pavelka T and Blauth M: Standardised cement augmentation of the PFNA using a perforated blade: A new technique and preliminary clinical results. A prospective multicentre trial. Injury. 42:1484–1490. 2011.PubMed/NCBI View Article : Google Scholar

11 

Fensky F, Nüchtern JV, Kolb JP, Huber S, Rupprecht M, Jauch SY, Sellenschloh K, Püschel K, Morlock MM, Rueger JM and Lehmann W: Cement augmentation of the proximal femoral nail antirotation for the treatment of osteoporotic pertrochanteric fractures-a biomechanical cadaver study. Injury. 44:802–807. 2013.PubMed/NCBI View Article : Google Scholar

12 

Erhart S, Schmoelz W, Blauth M and Lenich A: Biomechanical effect of bone cement augmentation on rotational stability and pull-out strength of the proximal femur nail antirotation™. Injury. 42:1322–1327. 2011.PubMed/NCBI View Article : Google Scholar

13 

Lu JX, Huang ZW, Tropiano P, Clouet D'Orval B, Remusat M, Dejou J, Proust JP and Poitout D: Human biological reactions at the interface between bone tissue and polymethylmethacrylate cement. J Mater Sci Mater Med. 13:803–809. 2002.PubMed/NCBI View Article : Google Scholar

14 

Stańczyk M and van Rietbergen B: Thermal analysis of bone cement polymerisation at the cement-bone interface. J Biomech. 37:1803–1810. 2004.PubMed/NCBI View Article : Google Scholar

15 

Boner V, Kuhn P, Mendel T and Gisep A: Temperature evaluation during PMMA screw augmentation in osteoporotic bone-an in vitro study about the risk of thermal necrosis in human femoral heads. J Biomed Mater Res B Appl Biomater. 90:842–848. 2009.PubMed/NCBI View Article : Google Scholar

16 

Fliri L, Lenz M, Boger A and Windolf M: Ex vivo evaluation of the polymerization temperatures during cement augmentation of proximal femoral nail antirotation blades. J Trauma Acute Care Surg. 72:1098–1101. 2012.PubMed/NCBI View Article : Google Scholar

17 

Shin SJ and Lee JH and Lee JH: Influence of hydroxyapatite stick on pedicle screw fixation in degenerative lumbar spine: Biomechanical and radiologic study. Clin Spine Surg. 30:E819–E826. 2017.PubMed/NCBI View Article : Google Scholar

18 

Hofmann A, Gorbulev S, Guehring T, Schulz AP, Schupfner R, Raschke M, Huber-Wagner S and Rommens PM: CERTiFy Study Group. Autologous iliac bone graft compared with biphasic hydroxyapatite and calcium sulfate cement for the treatment of bone defects in tibial plateau fract: A prospective, randomized, open-label, multicenter study. J Bone Joint Surg Am. 102:179–193. 2020.PubMed/NCBI View Article : Google Scholar

19 

Tami AE, Leitner MM, Baucke MG, Mueller TL, van Lenthe GH, Müller R and Ito K: Hydroxyapatite particles maintain peri-implant bone mantle during osseointegration in osteoporotic bone. Bone. 45:1117–1124. 2009.PubMed/NCBI View Article : Google Scholar

20 

Ohe M, Moridaira H, Inami S, Takeuchi D, Nohara Y and Taneichi H: Pedicle screws with a thin hydroxyapatite coating for improving fixation at the bone-implant interface in the osteoporotic spine: Experimental study in a porcine model. J Neurosurg Spine. 28:679–687. 2018.PubMed/NCBI View Article : Google Scholar

21 

Reynolds KJ, Cleek TM, Mohtar AA and Hearn TC: Predicting cancellous bone failure during screw insertion. J Biomech. 46:1207–1210. 2013.PubMed/NCBI View Article : Google Scholar

22 

Suhm N, Hengg C, Schwyn R, Windolf M, Quarz V and Hänni M: Mechanical torque measurement predicts load to implant cut-out: A biomechanical study investigating DHS anchorage in femoral heads. Arch Orthop Trauma Surg. 127:469–474. 2007.PubMed/NCBI View Article : Google Scholar

23 

Ab-Lazid R, Perilli E, Ryan MK, Costi JJ and Reynolds KJ: Does cancellous screw insertion torque depend on bone mineral density and/or microarchitecture? J Biomech. 47:347–353. 2014.PubMed/NCBI View Article : Google Scholar

24 

Iwata H, Takada N, Kuroyanagi G, Ikuta K, Usami T, Sekiya I and Murakami H: Effect of hydroxyapatite tubes on the lag screw intraoperative insertion torque for the treatment of intertrochanteric femoral fractures. Injury. 52:3377–3381. 2021.PubMed/NCBI View Article : Google Scholar

25 

Baumgaertner MR, Curtin SL, Lindskog DM and Keggi JM: The value of the tip-apex distance in predicting failure of fixation of peritrochanteric fractures of the hip. J Bone Joint Surg Am. 77:1058–1064. 1995.PubMed/NCBI View Article : Google Scholar

26 

Kane P, Vopat B, Heard W, Thakur N, Paller D, Koruprolu S and Born C: Is tip apex distance as important as we think? A biomechanical study examining optimal lag screw placement. Clin Orthop Relat Res. 472:2492–2498. 2014.PubMed/NCBI View Article : Google Scholar

27 

Pintus E, Sorbolini S, Albera A, Gaspa G, Dimauro C, Steri R, Marras G and Macciotta NP: Use of locally weighted scatterplot smoothing (LOWESS) regression to study selection signatures in piedmontese and Italian brown cattle breeds. Anim Genet. 45:1–11. 2014.PubMed/NCBI View Article : Google Scholar

28 

Tamaddon M, Chen SM, Vanaclocha L, Hart A, El-Husseiny M, Henckel J and Liu C: Decrease in local volumetric bone mineral density in osteoarthritic joints is associated with the increase in cartilage damage: A peripheral quantitative CT study. Fron Mater. 4(37)2017.

29 

Hasegawa K, Yamamura S and Dohmae Y: Enhancing screw stability in osteosynthesis with hydroxyapatite granules. Arch Orthop Trauma Surg. 117:175–176. 1998.PubMed/NCBI View Article : Google Scholar

30 

Yamada M, Ueno T, Tsukimura N, Ikeda T, Nakagawa K, Hori N, Suzuki T and Ogawa T: Bone integration capability of nanopolymorphic crystalline hydroxyapatite coated on titanium implants. Int J Nanomedicine. 7:859–873. 2012.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Usami T, Takada N, Iwata H, Sakai H, Hattori Y, Sekiya I, Ueki Y, Nagaya Y, Murakami H, Kuroyanagi G, Kuroyanagi G, et al: A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures. Exp Ther Med 25: 256, 2023.
APA
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I. ... Kuroyanagi, G. (2023). A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures. Experimental and Therapeutic Medicine, 25, 256. https://doi.org/10.3892/etm.2023.11955
MLA
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I., Ueki, Y., Nagaya, Y., Murakami, H., Kuroyanagi, G."A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures". Experimental and Therapeutic Medicine 25.6 (2023): 256.
Chicago
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I., Ueki, Y., Nagaya, Y., Murakami, H., Kuroyanagi, G."A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures". Experimental and Therapeutic Medicine 25, no. 6 (2023): 256. https://doi.org/10.3892/etm.2023.11955
Copy and paste a formatted citation
x
Spandidos Publications style
Usami T, Takada N, Iwata H, Sakai H, Hattori Y, Sekiya I, Ueki Y, Nagaya Y, Murakami H, Kuroyanagi G, Kuroyanagi G, et al: A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures. Exp Ther Med 25: 256, 2023.
APA
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I. ... Kuroyanagi, G. (2023). A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures. Experimental and Therapeutic Medicine, 25, 256. https://doi.org/10.3892/etm.2023.11955
MLA
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I., Ueki, Y., Nagaya, Y., Murakami, H., Kuroyanagi, G."A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures". Experimental and Therapeutic Medicine 25.6 (2023): 256.
Chicago
Usami, T., Takada, N., Iwata, H., Sakai, H., Hattori, Y., Sekiya, I., Ueki, Y., Nagaya, Y., Murakami, H., Kuroyanagi, G."A biomechanical analysis of the effect of hydroxyapatite augmentation for trochanteric femoral fractures". Experimental and Therapeutic Medicine 25, no. 6 (2023): 256. https://doi.org/10.3892/etm.2023.11955
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team